DXCM 53.56 Dexcom Inc $DXCM Hit a 52 week high of 53.74

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
DXCM 53.56 Dexcom Inc $DXCM Hit a 52 week high of 53.74 Closing the day 09:44 at 53.56 -0.45 -0.83% With a day low of 53.36 and a total volume of 38,673.

DXCM Recent Posts: http://investorshangout.com/DexCom-Inc-DXCM-53952/

DXCM Dexcom Inc Recent Headline News

DexCom Scales 52-Week High on Product Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 1:10PM CST
Impressive third-quarter 2014 results, recent FDA approvals for its new products along with a robust product pipeline contribute to the growth trajectory of DexCom, Inc. (DXCM), creating good momentum for 2015 as well.
ABT: 44.65 (+0.42), JNJ: 109.04 (+0.29), DXCM: 54.19 (+0.18), MDT: 69.41 (+0.91)

DexCom G4 Platinum Software Gains FDA Nod, Shares Surge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:54PM CST
Following the announcement, shares of DexCom, Inc. (DXCM) shot up nearly 14.12% to close at $50.93 in the last trading session.
ABT: 44.65 (+0.42), JNJ: 109.04 (+0.29), DXCM: 54.19 (+0.18), MDT: 69.41 (+0.91)

DexCom Has Returned 17.2% Since SmarTrend Recommendation (DXCM)
Comtex SmarTrend(R) - Mon Nov 10, 9:32AM CST
SmarTrend identified an Uptrend for DexCom (NASDAQ XCM) on October 21st, 2014 at $43.32. In approximately 3 weeks, DexCom has returned 17.21% as of today's recent price of $50.77.
DXCM: 54.19 (+0.18)

Strength Seen in DexCom (DXCM): Stocks Gains 14.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:46AM CST
DexCom (DXCM) was a big mover last session, with shares rising over 14% on the day.
ABMD: 33.27 (-0.33), DXCM: 54.19 (+0.18), EW: 124.48 (+1.53), ANGO: 16.95 (-0.03)

Hologic Beats Q4 Earnings, Sales as All Segments Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 1:50PM CST
Hologic (HOLX) entered into an amended license agreement with Roka Bioscience, which earned a one-time revenue benefit of $20.1 million for Hologic
ABMD: 33.27 (-0.33), DXCM: 54.19 (+0.18), ANGO: 16.95 (-0.03), HOLX: 26.70 (+0.15)

Watch Out: Barbarians At The Gate For DexCom (DXCM)
at The Street - Fri Nov 07, 8:55AM CST
Trade-Ideas LLC identified DexCom (DXCM) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
DXCM: 54.19 (+0.18)

Foundation Medicine Slumps: FMI Tumbles 9.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:59AM CST
Foundation Medicine has been witnessing a flat trend in its current year earnings estimate and its share price has been falling for past 24 hours
ABMD: 33.27 (-0.33), DXCM: 54.19 (+0.18), FMI: 25.11 (+0.01), ANGO: 16.95 (-0.03)

DexCom's (DXCM) CEO Terry Gregg on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 9:13PM CST

DXCM: 54.19 (+0.18)

DexCom misses by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:09PM CST

DXCM: 54.19 (+0.18)

DexCom (DXCM) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 3:25PM CST

DXCM: 54.19 (+0.18)

DexCom, Inc. Reports Third Quarter 2014 Financial Results
Business Wire - Thu Nov 06, 3:02PM CST
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended September 30, 2014.
DXCM: 54.19 (+0.18)

FDA Approves Dexcom Software with Artificial Pancreas Algorithm
Business Wire - Thu Nov 06, 7:30AM CST
Dexcom, Inc., (NASDAQ XCM), a leader in continuous glucose monitoring (CGM), announced today that the U.S. Food and Drug Administration (FDA) has approved new software for the Dexcom G4(R) PLATINUM CGM. The new Software 505 features the same advanced algorithm as used in artificial pancreas research around the world. The software will impact the performance of the Dexcom G4 PLATINUM, already considered the most accurate CGM system on the market today. The software will be made available free of charge to adult patients using the Dexcom G4 PLATINUM.
DXCM: 54.19 (+0.18)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:35PM CST

BEBE: 2.44 (-0.03), ACET: 21.33 (-0.23), ANET: 77.70 (+0.46), FNGN: 32.38 (+0.10), CPST: 0.96 (-0.02), AUQ: 3.60 (+0.02), AMRN: 0.93 (+0.04), ED: 62.31 (+0.06), ENV: 53.94 (-0.31), FXCM: 16.58 (+0.02), BCEI: 38.08 (-2.07), GXP: 26.77 (+0.05), EAC: 12.46 (+0.16), DXCM: 54.19 (+0.18), CSC: 61.10 (-0.15), AEL: 27.18 (+0.33), HNSN: 0.85 (+0.09), CFN: 57.59 (+0.03), ANAC: 31.50 (-0.27), DAR: 18.80 (-0.03), GST: 3.94 (-0.14), ARC: 10.04 (+0.11), FIVN: 4.95 (+0.04), ELON: 1.93 (+0.01), FSLR: 47.69 (-1.90), EZPW: 11.22 (-0.06), ALIM: 5.27 (+0.06), FWM: 2.29 (-0.02), BRS: 71.19 (-1.58), ECOM: 18.91 (+0.15), FTEK: 3.95 (-0.03), CVT: 28.14 (-0.09), AL: 36.96 (-0.32), BBRG: 13.41 (+0.01), BPZ: 0.90 (-0.04), ECPG: 45.46 (-0.27), HTGC: 15.41 (-0.56), AIRM: 44.05 (+0.04), BNFT: 27.81 (+0.21), ENOC: 14.60 (-0.55), HPTX: 21.59 (-0.11), AGO: 24.81 (+0.09), FICO: 71.84 (+0.09), FF: 12.48 (-0.02), FI: 20.15 (-0.09), EVC: 5.29 (+0.05), EBS: 24.71 (-0.21), ABCO: 46.22 (-1.92), DIOD: 26.39 (unch), DIS: 90.60 (+0.70), EGOV: 17.47 (-0.12), APEI: 36.80 (+0.24), DVA: 76.93 (+0.21), CLVS: 57.71 (-0.73), HCI: 42.64 (+0.67), BRKR: 18.39 (-0.03), HGR: 21.18 (+0.47)

DexCom Announces Upcoming Conference Presentations
Business Wire - Thu Oct 30, 7:30AM CDT
DexCom, Inc. (NASDAQ XCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:
DXCM: 54.19 (+0.18)

Forget MannKind Corporation: 3 Better Stocks
Motley Fool Staff - Motley Fool - Mon Oct 27, 8:13AM CDT
Source: MannKind. A doubling of Americans diagnosed with diabetes over the coming decade may support demand for  MannKind 's inhalable insulin Afrezza, but that doesn't necessarily mean that MannKind is biotech's best idea. We asked three of...
DXCM: 54.19 (+0.18), NVAX: 5.31 (+0.07), AGIO: 85.93 (-0.94), SNY: 46.78 (+0.22), MNKD: 6.23 (+0.15), CELG: 107.74 (-0.51)

DexCom reports November 6
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 9:43AM CDT

DXCM: 54.19 (+0.18)

DexCom Schedules Third Quarter 2014 Earnings Release and Conference Call for November 6, 2014 at 4:30 p.m. Eastern Time
Business Wire - Thu Oct 23, 7:31AM CDT
DexCom, Inc. (NASDAQ XCM) today announced that it plans to release its third quarter 2014 financial results after market close on Thursday, November 6, 2014. Management will hold a conference call to review the company's third quarter 2014 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to "Our Company," then "Investor Relations," and then "Events and Webcasts," and will be archived there for future reference.
DXCM: 54.19 (+0.18)

FDA Approves Dexcom SHARE(TM), the First Remote Mobile Communications Device Used for Continuous Glucose Monitoring (CGM)
Business Wire - Mon Oct 20, 8:24AM CDT
Dexcom, Inc. (NASDAQ XCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM remote mobile communications device: Dexcom SHARE. Dexcom SHARE, an accessory to the Dexcom G4(R) PLATINUM Continuous Glucose Monitoring System, uses a secure wireless connection to transmit the glucose levels of a person with diabetes to the smartphones of up to five designated recipients, or "followers." These followers can remotely monitor a patient's glucose information and receive alert notifications from almost anywhere via their Apple(R) iPhone(R) or iPod(R) touch. With Dexcom SHARE, parents and personal caregivers can monitor a child's or loved one's glucose data from a remote location, giving them peace of mind and reassurance when they are apart.
DXCM: 54.19 (+0.18)

MFG, PGTI, MWIV, BKD, AREX, DXCM Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Oct 06, 6:29AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Mizuho Financial Group Inc (NYSE:MFG), PGT Inc (NASDAQ GTI), MWI Veterinary Supply Inc (NASDAQ:MWIV), BROOKDALE SENIOR LIVING INC. (NYSE:BKD), Approach Resources Inc (NASDAQ:AREX), DexCom Inc (NASDAQ XCM) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
MFG: 3.57 (+0.01), DXCM: 54.19 (+0.18), MWIV: 157.90 (+1.86), PGTI: 9.85 (-0.13), BKD: 32.86 (-0.02), AREX: 11.35 (-0.59)

The Stunning Mobile Game Changer for Diabetics That Investors Can't Ignore
Leo Sun, The Motley Fool - Motley Fool - Sun Oct 05, 8:31AM CDT
Ever since Apple launched the first iPhone nearly seven years ago, developers have released mobile apps and connected devices to improve the lives of diabetes patients. These products helped diabetics track meals, insulin dosages, glucose...
JNJ: 109.03 (+0.28), DXCM: 54.19 (+0.18), MDT: 69.41 (+0.91), SNY: 46.78 (+0.22), AAPL: 112.76 (+1.51)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PolyBio Convergence Summit Tackles Aging, Chronic Illness

Updated Category News Views 146

Kicking Off The Convergence: Pathogens in Focus Here's a gathering that's set to challenge how we think about lingering illnesses and aging. PolyBio Research Foundation is bringing a powerhouse of brains to the table with their inaugural Convergence Summit. It's more than just science talk; it's a chance to push boundaries in understanding how pathogens stick around and...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 69

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 142

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 155

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
equipifi's BNPL Shop: New Ammo for Credit Unions

Updated Category News Views 87

equipifi's 'Shop': The Big Play in Banking Look, here’s the deal—equipifi just lobbed a new grenade into the finance battlefield, arming credit unions and community banks with 'Shop', their own Buy Now, Pay Later (BNPL) platform. The goal? To put them toe-to-toe with the big fintech wolves—something these smaller guys desperately needed. It's a meaty move, no...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 71

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Thread AI Joins Microsoft Pegasus: Big AI Leap

Updated Category News Views 26

Thread AI Leaps Ahead with Microsoft Partnership There's excitement in the air as Thread AI joins forces with Microsoft by entering the exclusive Pegasus Program. In the ever-evolving world of AI, making a splash this big doesn't happen every day. People in the tech alley are buzzing, and it looks like Thread AI is ready to rumble on a larger stage—much like a scrappy...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 85

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 67

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 135

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading

Top 5 Most Recently Viewed Articles

Cytek Biosciences Prepares for Q2 2025 Financial Results Report

Updated Category News Views 214

Cytek Biosciences Plans Financial Disclosure for Second Quarter 2025 Cytek Biosciences, Inc. (NASDAQ: CTKB), based in Fremont, California, has dynamic news for stakeholders. The company is set to disclose its financial results for the second quarter of 2025 on August 6, 2025. This critical deadline follows the market closure that day, allowing for a comprehensive analysis...

Continue Reading
Alliance Trust PLC Shares Up: Latest NAV Per Share Insights

Updated Category News Views 171

Alliance Trust PLC Alliance Trust PLC's recent trading data dropped some key numbers that had traders buzzing. The Net Asset Value (NAV) per ordinary share hit the screens, giving everyone a fresh angle on how the company was really performing in a choppy market. NAV Breakdown: What's It Telling Us? Here's how the NAV shook out on the latest report: Valued on a Bid Price...

Continue Reading
Man Group Investment Insights: Spirent Communications and Trends

Updated Category News Views 199

Investment Insights from Man Group regarding Spirent Communications In today’s evolving market, understanding the dynamics between significant firms like Man Group PLC and Spirent Communications plc is vital for investors. This disclosure provides a snapshot of Man Group’s holdings and interests, particularly in relation to investing more than 1% in relevant...

Continue Reading
Sunny Lowe Joins Prime Mining Corp's Board of Directors

Updated Category News Views 221

Prime Mining Corp. (TSX: PRYM) (Other OTC: PRMNF) (Frankfurt: O4V3) has recently appointed Sunny Lowe to its Board of Directors. This announcement highlights a strategic move by the company to strengthen its leadership team as it continues its key projects, particularly the Los Reyes Project. Welcome to Sunny Lowe Murray John, Chair of the Board, expressed enthusiasm...

Continue Reading
Spotlight on Magnificent 7 Stocks: Opportunities in a Turbulent Market

Updated Category News Views 190

Market Overview: Understanding the Current Landscape The technology sector has seen major fluctuations recently, prompting discussions about the best investment opportunities. Economic uncertainties and market instability have resulted in significant stock losses, making this a pivotal moment for investors. The backdrop of Trump’s trade policies adds another layer of...

Continue Reading